Showing results (21-30 of 42) with videos related to
Sort By:
Pageof 5
Psychiatry Research|January 19, 2010
Obesity and smoking in patients with schizophrenia and normal controls: a case-control studyKonstantinos N Fountoulakis, Melina Siamouli, Panagiotis Panagiotidis, et al.Anti-Cancer Drugs|June 30, 2011
Translocation t(12;13)(p13;q14) in a patient with imatinib-sensitive MDS/MPD associated with resistance to treatment: review of the literaturePanagiotis T Diamantopoulos, Anastasia Athanasiadou, Evangelos Papakostas, et al.Journal of Affective Disorders|July 18, 2006
Comparison of depressive indices: reliability, validity, relationship to anxiety and personality and the role of age and life eventsKonstantinos N Fountoulakis, Per Bech, Panagiotis Panagiotidis, et al.British Journal of Haematology|April 3, 2020
A five-year follow-up of untreated patients with chronic lymphocytic leukaemia treated with ofatumumab and chlorambucil: final analysis of the Complement 1 phase 3 trialFritz Offner, Tadeusz Robak, Ann Janssens, et al.Journal of Affective Disorders|March 25, 2014
Standardization of the TEMPS-A in the Greek general populationKonstantinos N Fountoulakis, Melina Siamouli, Matina Magiria, et al.Haematologica|December 7, 2014
Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical settingLesley-Ann Sutton, Viktor Ljungström, Larry Mansouri, et al.Annals of General Psychiatry|December 16, 2014
Standardization of the NEO-PI-3 in the Greek general populationKonstantinos N Fountoulakis, Melina Siamouli, Stefania Moysidou, et al.British Journal of Haematology|February 18, 2026
Clinical outcomes of patients with lower risk myelodysplastic syndrome from EUMDS registry eligible for transplantation: Implications for transplantation strategiesAleksandar Savic, Adele Taylor, Pierre Fenaux, et al.Haematologica|October 15, 2020
Prognostic and predictive role of gene mutations in chronic lymphocytic leukemia: results from the pivotal phase III study COMPLEMENT1Eugen Tausch, Philipp Beck, Richard F Schlenk, et al.Lancet (London, England)|April 18, 2015
Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label phase 3 trialPeter Hillmen, Tadeusz Robak, Ann Janssens, et al.Pageof 5